The Congress “20 Clinical Cases in Trichology 2022” held on January 29, 2022 at the Tuscany Inn Hotel in Montecatini Terme was a huge success throughout the scientific community of medical specialists in the field: all thanks to the topics covered and its innovative formula that allowed it to be transformed into a unique and highly educational event. Recall that the convention was sponsored by the S.I.Tri., the Italian Society of Trichology, and the Scientific Coordinator of the Congress was Prof. Andrea Marliani, president emeritus of the S.I.Tri., flanked by Dr. Fiorella Bini, current president of the S.I.Tri., and Dr. Piero Tesauro, vice-president of the S.I.Tri., as well as all the members of its board.

For those who missed it, or were unable to attend, here is a little reminder!

The Congress was held from 8:30 a.m. to 6 p.m. and involved more than one hundred medical specialists working in the fields of Trichology, Dermatology and Nutrition. The focus of the entire event organized by Wikenfarma was clear from the start: the patient has become and is the center of the universe not only of the physicians, but also of the company itself, which conceives and formulates its products based on the real needs of each individual. In his opening remarks, Dr. Massimiliano De Carlo – CEO of Wikenfarma – specified how each individual formulation of the RESTAX range is based on very specific distinctions involving three main factors:

– Pathology
– Age
– Biological sex

The importance of such a distinction, lies in the fact that each individual therapy is tailored to the patient, that it is personalized to be able to respond to his or her needs and requirements in a precise and specific manner as scientist Claudius Galen taught in the past. According to these principles, in fact, products such as Restax Donna, Restax Donna Plus and Restax Effluvium were born , specific respectively to treat female androgenetic alopecia in women of childbearing age and post-menopausal women or, in the case of Restax Effluvium, to treat stress-related telogen effluvium.
In addition, the various products can boast of BIPHASIC, TRIPHASIC or QUADRIPHASIC formulations (such as Restax Men’s and Women’s Lotion specifically for Telogen Effluvium): innovative nutraceutical compounds for the synergy between several active ingredients with high titrations that guarantee proven efficacy from the very first month of therapy.